CVR number 38899899
Industry 86.9040 Other human health activities

KIROPRAKTOR.COM ApS ODENSE

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  3.0% 3.7% 3.6% 3.3% 2.3%  
Credit score (0-100)  58 52 51 54 63  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  1,822 2,058 2,524 2,602 2,946  
EBITDA  267 227 350 340 490  
EBIT  6.2 -11.4 102 100 234  
Pre-tax profit (PTP)  -171.5 -179.8 -61.1 -125.7 1.1  
Net earnings  -133.8 -140.2 -197.6 -125.7 101.1  
Pre-tax profit without non-rec. items  -172 -180 -61.1 -126 1.1  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  1,839 1,997 1,929 2,037 1,960  
Shareholders equity total  -653 -793 -990 -1,116 -1,015  
Interest-bearing liabilities  3,855 2,480 2,672 2,756 2,418  
Balance sheet total (assets)  3,486 3,504 3,170 3,200 3,081  
Net Debt  3,810 2,417 2,597 2,688 2,259  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,822 2,058 2,524 2,602 2,946  
Gross profit growth  2.0% 12.9% 22.6% 3.1% 13.2%  
Employees  4 4 4 3 4  
Employee growth %  0.0% 0.0% 0.0% -25.0% 33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,486 3,504 3,170 3,200 3,081  
Balance sheet change%  -3.6% 0.5% -9.5% 0.9% -3.7%  
Added value  266.6 226.6 349.9 347.4 489.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -404 -259 -495 -311 -512  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 -1.0 1.0 2.0 3.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.3% -0.6% 4.1% 3.8% 7.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.1% -0.3% 2.4% 2.4% 5.6%  
ROI %  0.2% -0.4% 3.9% 3.7% 9.0%  
ROE %  -3.8% -4.0% -5.9% -3.9% 3.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -15.8% -18.5% -23.8% -25.9% -24.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1,429.4% 1,066.4% 742.4% 789.6% 461.1%  
Gearing %  -590.9% -312.8% -269.9% -246.9% -238.3%  
Net interest  0 0 0 0 0  
Financing costs %  4.6% 5.3% 6.3% 8.3% 9.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.1 0.1 0.1 0.1 0.1  
Current Ratio  0.1 0.1 0.1 0.1 0.1  
Cash and cash equivalent  45.1 63.1 75.2 67.5 158.8  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -2,556.4 -2,730.6 -2,930.6 -3,193.9 -3,087.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  67 57 87 116 122  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  67 57 87 113 122  
EBIT / employee  2 -3 26 33 58  
Net earnings / employee  -33 -35 -49 -42 25